Appeal No. 1997-3040
Application No. 08/477,729
The examiner relies upon the following references as
evidence of obviousness:
Kadin 4,569,942 Feb. 11, 1986
Young et al. (Young) 4,962,117 Oct. 09, 1990
Appellants' claimed invention is directed to 3-
substituted-2-oxindole derivatives and salts thereof that are
defined by the recited formula (I). The claimed compounds are
used to treat inflamatory conditions, to elicit an analgesic
response, to treat interleukin-1 mediated disorders and immune
disfunction, to inhibit prostaglandin H synthase, and to
2
inhibit biosynthesis of interleukin-1 in a mammal.
The present application is related to appellants'
application, U.S. Application No. 08/148,764, filed
November 4, 1993. An appeal was taken to this Board in the
related case and, in a decision dated April 8, 1998, this
Board reversed the examiner's rejections under 35 U.S.C. § 103
over the same prior art references presently applied by the
examiner (Appeal No. 96-2721).
The appealed claims stand rejected under 35 U.S.C. § 103
as being unpatentable over Kadin. In addition, the appealed
claims stand rejected under 35 U.S.C. § 103 as being
unpatentable over Kadin in view of Young.
-2-
Page: Previous 1 2 3 4 5 6 7 8 9 10 Next
Last modified: November 3, 2007